India's Marksans Pharma rises after unit gets marketing approval for drug

Marksans Pharma

20/11/2025 08:14

** Shares of Marksans Pharma MARK.NS rise 2% to 192 rupees, snapping a two-day losing streak

** Pharma co's UK unit gets approval to market its product Cetirizine

** More than 570,400 shares change hands by 1:35 pm IST vs 30-day avg of 1.4 mln shares

** YTD, however, MARK is down 35%

 (Reporting by Komal Salecha)

 ((Komal@thomsonreuters.com;))